ArticleWorld journal of surgical oncology2021

MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1.

Mengning Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.